DREAM3R: DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma: A Phase 3 Randomised Trial

P. Forde, H. Kindler, M. Zauderer, Z. Sun, S. Ramalingam, V. Anagnostou, J. R. Brahmer, A. K. Nowak, P. S. Kok, C. Brown, S. Yip, A. Cook, W. J. Lesterhuis, B. G. M. Hughes, N. Pavlakis, M. R. Stockler, K. J. O'Byrne

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

Original languageEnglish
Pages (from-to)E9-E10
Number of pages2
JournalInternational Journal of Radiation Oncology Biology Physics
Issue number2
Publication statusPublished - 1 Feb 2022

Cite this